Literature DB >> 28627690

Data mining and pathway analysis of glucose-6-phosphate dehydrogenase with natural language processing.

Long Chen1, Chunhua Zhang1, Yanling Wang1, Yuqian Li1, Qiaoqiao Han1, Huixin Yang1, Yuechun Zhu1.   

Abstract

Human glucose-6-phosphate dehydrogenase (G6PD) is a crucial enzyme in the pentose phosphate pathway, and serves an important role in biosynthesis and the redox balance. G6PD deficiency is a major cause of neonatal jaundice and acute hemolyticanemia, and recently, G6PD has been associated with diseases including inflammation and cancer. The aim of the present study was to conduct a search of the National Center for Biotechnology Information PubMed library for articles discussing G6PD. Genes that were identified to be associated with G6PD were recorded, and the frequency at which each gene appeared was calculated. Gene ontology (GO), pathway and network analyses were then performed. A total of 98 G6PD‑associated genes and 33 microRNAs (miRNAs) that potentially regulate G6PD were identified. The 98 G6PD‑associated genes were then sub‑classified into three functional groups by GO analysis, followed by analysis of function, pathway, network, and disease association. Out of the 47 signaling pathways identified, seven were significantly correlated with G6PD‑associated genes. At least two out of four independent programs identified the 33 miRNAs that were predicted to target G6PD. miR‑1207‑5P, miR‑1 and miR‑125a‑5p were predicted by all four software programs to target G6PD. The results of the present study revealed that dysregulation of G6PD was associated with cancer, autoimmune diseases, and oxidative stress‑induced disorders. These results revealed the potential roles of G6PD‑regulated signaling and metabolic pathways in the etiology of these diseases.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28627690      PMCID: PMC5562079          DOI: 10.3892/mmr.2017.6785

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  72 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 2.  MicroRNAs and metabolism crosstalk in energy homeostasis.

Authors:  Olivier Dumortier; Charlotte Hinault; Emmanuel Van Obberghen
Journal:  Cell Metab       Date:  2013-07-11       Impact factor: 27.287

3.  miRNA-124 down-regulates SOX8 expression and suppresses cell proliferation in non-small cell lung cancer.

Authors:  Chao Xie; Yunwei Han; Yi Liu; Lei Han; Jie Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

4.  Cytokine responses of TNF-α, IL-6, and IL-10 in G6PD-deficient infants.

Authors:  Sui-Ling Liao; Shen-Hao Lai; Ming-Han Tsai; Yi-Hao Weng
Journal:  Pediatr Hematol Oncol       Date:  2014-01-02       Impact factor: 1.969

5.  Oxidant/antioxidant status in cattle with liver cystic echinococcosis.

Authors:  M Heidarpour; M Mohri; H Borji; E Moghdass
Journal:  Vet Parasitol       Date:  2013-01-30       Impact factor: 2.738

6.  Importance of glucose-6-phosphate dehydrogenase activity in cell death.

Authors:  W N Tian; L D Braunstein; K Apse; J Pang; M Rose; X Tian; R C Stanton
Journal:  Am J Physiol       Date:  1999-05

7.  Increased prevalence of proliferative retinopathy in patients with type 1 diabetes who are deficient in glucose-6-phosphate dehydrogenase.

Authors:  G Cappai; M Songini; A Doria; J D Cavallerano; M Lorenzi
Journal:  Diabetologia       Date:  2011-03-05       Impact factor: 10.122

8.  [Determination of superoxide dismutase (sod) in erythrocytes in glucose-6-phosphate dehydrogenase deficiency (G6PD-deficiency)].

Authors:  M Grieger; S Schulz
Journal:  Folia Haematol Int Mag Klin Morphol Blutforsch       Date:  1983

9.  The hypoxia-inducible microRNA cluster miR-199a∼214 targets myocardial PPARδ and impairs mitochondrial fatty acid oxidation.

Authors:  Hamid el Azzouzi; Stefanos Leptidis; Ellen Dirkx; Joris Hoeks; Bianca van Bree; Karl Brand; Elizabeth A McClellan; Ella Poels; Judith C Sluimer; Maarten M G van den Hoogenhof; Anne-Sophie Armand; Xiaoke Yin; Sarah Langley; Meriem Bourajjaj; Serve Olieslagers; Jaya Krishnan; Marc Vooijs; Hiroki Kurihara; Andrew Stubbs; Yigal M Pinto; Wilhelm Krek; Manuel Mayr; Paula A da Costa Martins; Patrick Schrauwen; Leon J De Windt
Journal:  Cell Metab       Date:  2013-09-03       Impact factor: 27.287

10.  starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data.

Authors:  Jun-Hao Li; Shun Liu; Hui Zhou; Liang-Hu Qu; Jian-Hua Yang
Journal:  Nucleic Acids Res       Date:  2013-12-01       Impact factor: 16.971

View more
  4 in total

1.  Relationship of Carbohydrate Metabolism and Molecular Genetic Markers in Gliomas with Different Degree of Anaplasia.

Authors:  L М Obukhova; О N Nikiforova; Т V Kopytova; N Yu Orlinskaya; М М Kontorshchikov; K N Kontorshchikova; I А Medyanik; А S Grishin; D D Vasina
Journal:  Bull Exp Biol Med       Date:  2021-11-18       Impact factor: 0.804

Review 2.  History and Future Perspectives on the Discipline of Quantitative Systems Pharmacology Modeling and Its Applications.

Authors:  Karim Azer; Chanchala D Kaddi; Jeffrey S Barrett; Jane P F Bai; Sean T McQuade; Nathaniel J Merrill; Benedetto Piccoli; Susana Neves-Zaph; Luca Marchetti; Rosario Lombardo; Silvia Parolo; Selva Rupa Christinal Immanuel; Nitin S Baliga
Journal:  Front Physiol       Date:  2021-03-25       Impact factor: 4.566

3.  Transcriptomic Analysis of Fumarate Compounds Identifies Unique Effects of Isosorbide Di-(Methyl Fumarate) on NRF2, NF-kappaB and IRF1 Pathway Genes.

Authors:  William R Swindell; Krzysztof Bojanowski; Ratan K Chaudhuri
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-11

4.  Correcting glucose-6-phosphate dehydrogenase deficiency with a small-molecule activator.

Authors:  Sunhee Hwang; Karen Mruk; Simin Rahighi; Andrew G Raub; Che-Hong Chen; Lisa E Dorn; Naoki Horikoshi; Soichi Wakatsuki; James K Chen; Daria Mochly-Rosen
Journal:  Nat Commun       Date:  2018-10-02       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.